Development and validation of a chromatographic method for determining Clematichinenoside AR and related impurities

Chemistry Central Journal

Lifang Liu¹  Lan Yao¹  Xiaolin Zhang¹  Ji Shi¹  Yue Guan¹  Yang Zhou¹ 

[1]The State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China

关键词: Correction factors;    HPLC-UV;    Related impurities;    Clematichinenoside AR;   

Others  :  788005
DOI  :  10.1186/1752-153X-6-150

 received in 2012-09-24, accepted in 2012-11-27,  发布年份 2012

【 摘 要 】

Background

Clematichinenoside AR is a promising lead compound for the treatment of rheumatoid arthritis. A systematic research for the related impurities in AR bulk samples is still lacking. For the safe use of this natural product in future clinical practice, the structure and content of each constituent, including the main ingredient as well as the impurities in AR bulk sample must be characterized in detail.

Results

A simple and stability indicating RP-HPLC method was developed and validated for determining the purity of clematichinenoside AR (AR), a natural product from the roots of Clematis manshurica Rupr. (Ranunculaceae) with the potential of treating rheumatoid arthritis. Five impurities were characterized, and impurity 2 (Clematomandshurica saponin F) is a new triterpenoid saponin isolated from this product. Optimum separation for clematichinenoside AR and five related impurities was carried out on an Agilent octadecylsilane bonded silica gel column (TC-C18, 4.6 mm ×150 mm, 5 μm) using a gradient HPLC method. The validation results showed good sensitivity, specificity, linearity(r²>0.9992) precision(RSD<1.63%), accuracy(recoveries in the range of 95.60%-104.76%) and robustness. Three AR bulk samples containing all the impurities were examined by two methods, and the stability of correction factors for the determination of related impurities was discussed. The proposed stability-indicating method was suitable for the quality control of this natural product.

Conclusion

Five related impurities of clematichinenoside AR were characterized, including a new triterpenoid saponins firstly found in clematichinenoside AR bulk samples. In the simple chromatographic method for determining clematichinenoside AR and its related impurities in bulk samples, the correction factor was better for the quality control in the relative stable concentrations.

【 授权许可】

   
2012 Zhou et al.; licensee Chemistry Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]The State Pharmacopoeia Commission of The People’s Republic of China: Pharmacopoeia of the People’s Republic of China. China Medical Science 2010, Volume 1:234.
• [2]Shi S, Jiang D, Zhao M, et al.: Preparative isolation and purification of triterpene saponins from Clematis mandshurica by high-speed counter-current chromatography coupled with evaporative light scattering detection. J Chromatogr B 2007, 852:679-683.
• [3]Mimaki Y, Yokosuka A, Hamanaka M, et al.: Triterpene saponins from the roots of Clematis chinensis. J Nat Prod 2004, 67:1511-1516.
• [4]Shi S, Jiang D, Dong C, et al.: Triterpene saponins from Clematis mandshurica. J Nat Prod 2006, 69:1591-1595.
• [5]Liu L, Ma X, Wang YX, et al.: Triterpenoid saponins from the roots of Clematis chinensis Osbeck. J Asian Nat Prod Res 2009, 11:389-396.
• [6]Wu W, Xu X, Dai Y, et al.: Therapeutic effect of the saponin fraction from clematis chinensis osbeck roots on osteoarthritis induced by monosodium iodoacetate through protecting articular cartilage. Phytother Res 2010, 24:538-546.
• [7]Fu Q, Zan K, Zhao M, et al.: Triterpene saponins from clematis chinensis and their potential anti-inflammatory activity. J Nat Prod 2010, 73:1234-1239.
• [8]Peng C, Perera PK, Li Y, et al.: Anti-inflammatory effects of Clematis chinensis Osbeck extract(AR-6) may be associated with NF-kB, TNF-a, and COX-2 in collagen-induced arthritis in rat. Rheumatol Int 2012, 32:3119-3125.
• [9]Lu X, Fang W, Li Y, et al.: Analgesic and anti-inflammatory effect of clematichinenoside. Chinese Journal of New Drugs 2009, 18:1535-1539.
• [10]Sun S, Li Y, Fang W, et al.: Effect and mechanism of AR-6 in experimental rheumatoid arthritis. Clin Exp Med 2010, 10:113-121.
• [11]Dong C, Liu L, Li M, et al.: The preparation and preliminary pharmacodynamics of clematichinenoside microemulsion. Chinese Traditional Patent Medicine 2011, 33(7):1159-1163.
• [12]Ma X, Xie L, Liu L, et al.: Simultaneous quantification of seven main triterpenoid saponins in Radix et Rhizoma Clematidis by LC–ELSD. Chromatographia 2009, 69:437-443.
• [13]Wang D, Li F, Li P, et al.: Validated LC-MS/MS assay for the quantitative determination of clematichinenoside AR in rat plasma and its application to a pharmacokinetic study. Biomed Chromatogr 2012, 26(10):1282-1285.
• [14]ICH: Q3A Impurities in New Drug Substances. Proceedings of the international conference on harmonization 2006, 1-22.
• [15]Kizu H, Shimana H, Tommimori T: Studies on the constituents constituents of Clematis Species IV. The Constituents of Clematis stans Sieb. Et Zucc. Chem Pharm Bull 1995, 43(12):2187-2194.
• [16]Shao B, Qin G, Xu R, et al.: Triterpenoid saponins fromClematis chinensis. Phytochemistry 1995, 38(6):1473-1479.
• [17]ICH: Q1A Stability Testing of New Drug Substances and Products. In Proceedings of the international conference on harmonization. 2003, 1-15.
• [18]Hou J, Wua W, Da J, et al.: Ruggedness and robustness of conversion factors in method of simultaneous determination of multi-components with single reference standard. J Chromatogr A 2011, 1218:5618-5627.
• [19]ICH: Q3B Impurities in New Drug Substances. In Proceedings of the international conference on harmonization. 2006, 1-12.